Most people encounter CJC-1295 and ipamorelin together - clinics prescribe them as a combo, forums discuss them as a pair, and it’s easy to assume they’re interchangeable. They’re not. These two peptides stimulate growth hormone through entirely different pathways, and understanding which one does what matters whether you’re running them solo, stacking them, or deciding where to put your money first.
Quick Comparison
| Feature | CJC-1295 | Ipamorelin |
|---|---|---|
| Primary Mechanism | GHRH analog - signals the pituitary to produce GH | Ghrelin mimetic - triggers GH release via the ghrelin receptor |
| Typical Dosing | 100-300 mcg/day (subcutaneous) | 100-300 mcg, 1-3x/day (subcutaneous) |
| Half-Life | ~30 min (no DAC) / ~8 days (with DAC) | ~2 hours |
| GH Release Pattern | Sustained elevation | Sharp, pulsatile burst |
| Cortisol/Prolactin Impact | Minimal | Minimal [1] |
| Appetite Effects | None significant | Does not increase hunger [2] |
| Best For | Sustained GH elevation, IGF-1 support, sleep | Targeted GH pulses, fat loss, recovery |
| Approximate Cost | ~$150/month (as part of a combo) | ~$150/month (as part of a combo) |
What Is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), the signal your hypothalamus sends to tell your pituitary gland to manufacture and secrete growth hormone. The peptide mimics that signal, effectively turning up the volume on your body’s own GH production line.
Two versions exist and the distinction matters. CJC-1295 without DAC (sometimes called Modified GRF 1-29) has a half-life of roughly 30 minutes and produces a more natural, pulsatile GH release. CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in the bloodstream, extending its half-life to around eight days and creating a more sustained GH elevation. Most clinical and anti-aging protocols use the no-DAC version because it better preserves the body’s natural GH rhythm. When you see “CJC-1295” prescribed at a peptide clinic alongside ipamorelin, it’s almost always the no-DAC variant.
The primary appeal is its ability to raise both growth hormone and IGF-1 levels over time, supporting improvements in body composition, connective tissue repair, and deep sleep architecture [3]. CJC-1295 doesn’t act on ghrelin receptors, so it won’t affect appetite or stimulate cortisol - a clean mechanism that makes it well-tolerated for most users.
What Is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue that works through the ghrelin receptor (GHS-R). Unlike CJC-1295, which tells the pituitary to make more GH, ipamorelin triggers the release of GH that’s already stored and ready. Think of CJC-1295 as increasing production capacity and ipamorelin as opening the warehouse doors.
What sets ipamorelin apart from older ghrelin mimetics like GHRP-6 and GHRP-2 is its selectivity. It stimulates GH release without meaningfully raising cortisol or prolactin [1], and critically, it does not spike appetite the way other GHRPs do [2]. That last point matters enormously for anyone using peptides during a cut or recomposition phase. GHRP-6 can make you ravenously hungry within minutes of injection. Ipamorelin doesn’t.
The GH pulse from ipamorelin is sharp and relatively short-lived, peaking within 30-40 minutes of injection and clearing within a few hours. This pulsatile pattern closely mirrors the body’s natural GH secretion, particularly the large pulse that occurs during early deep sleep. That’s one reason ipamorelin taken before bed tends to enhance sleep quality so dramatically - it amplifies a process your body is already trying to run [4].
Key Differences Between CJC-1295 and Ipamorelin
Mechanism of Action
This is the fundamental distinction and everything else flows from it. CJC-1295 works upstream at the GHRH receptor; ipamorelin works through the ghrelin receptor. They’re two completely separate signaling pathways that converge on the same target - the somatotroph cells in your anterior pituitary.
CJC-1295 says “make more growth hormone.” Ipamorelin says “release what you’ve got.” When you understand this, the logic of stacking them becomes obvious - and so do their individual strengths.
GH Release Pattern
CJC-1295 (no DAC) produces a broader, more gradual GH elevation. The pulse is real but more sustained, keeping GH and downstream IGF-1 elevated over a longer window. This makes it particularly effective for recovery, tissue repair, and the kind of slow-burn anabolic environment that supports lean muscle gain over months [3].
Ipamorelin produces a faster, more defined spike. GH shoots up, does its work, and clears. This pulsatile pattern is metabolically favorable - it more closely resembles the GH pulses of a healthy 25-year-old and tends to drive acute fat mobilization more effectively than a sustained elevation.
Side Effect Profile
Both peptides are remarkably clean compared to exogenous GH or older secretagogues. Neither significantly raises cortisol or prolactin [1]. Neither causes the water retention, joint pain, or insulin resistance commonly associated with synthetic HGH at bodybuilding doses.
The most reported side effects are mild: injection site redness, transient flushing, and occasionally light-headedness in the first few days. Some users report vivid dreams - a sign of enhanced deep sleep rather than a true side effect [4].
Where they diverge slightly: CJC-1295 with DAC (the long-acting version) can cause a sustained GH “bleed” that some users find leads to mild lethargy or water retention. This is why the no-DAC version dominates clinical protocols. Ipamorelin’s clean ghrelin-receptor selectivity means it avoids the hunger and cortisol issues that plague GHRP-2 and GHRP-6 [2].
Onset and Timeline
Neither peptide delivers overnight results. The combination of CJC-1295 and ipamorelin typically requires two to three months of consistent use before meaningful body composition changes become apparent [3]. Sleep improvements, however, show up much faster. One documented personal trial of the CJC/ipamorelin combo reported dramatically increased deep-sleep duration and dream recall within the first few days of an eight-week cycle [4].
Fat loss and lean muscle gains tend to materialize in the six-to-twelve-week window, with the most noticeable changes coming toward the end of a standard three-month cycle [3]. Cognitive improvements - better focus, mood stability - appear to be secondary effects of better sleep rather than direct peptide action [3].
CJC-1295 vs Ipamorelin: Which Should You Choose?
If your primary goal is fat loss without hunger disruption: Start with ipamorelin. Its ghrelin-receptor selectivity means you get GH-driven lipolysis without the appetite spikes that derail a caloric deficit [2]. Dose before bed on an empty stomach, and let the enhanced deep sleep do additional work on recovery and cortisol management.
If you want sustained IGF-1 elevation for recovery and tissue repair: CJC-1295 is the stronger choice. Its GHRH-mediated mechanism drives not just GH pulses but downstream IGF-1 production, which is the primary mediator of connective tissue repair, muscle protein synthesis, and the “healing” effects most people associate with growth hormone.
If you’re over 40 and want a general anti-aging protocol: The combination is the standard for a reason. A morning ipamorelin dose paired with an evening CJC-1295 dose produced noticeable fat loss, lean muscle gain, and consistent 92-95% sleep scores in one well-documented case - without any changes to diet or training [5]. That’s a compelling signal for a demographic where GH output has already declined 50-70% from peak levels.
If budget is a constraint: The combination runs approximately $300 per month through a prescribing clinic [1]. If you can only afford one, ipamorelin tends to be the more immediately noticeable peptide due to its sharp GH pulses and rapid sleep improvement. CJC-1295’s benefits are real but more gradual and subtle.
If you have thyroid concerns: Both peptides have been discussed in the context of thyroid-related symptoms - hair loss, skin dryness, the slow metabolic decline that accompanies subclinical hypothyroidism. Growth hormone peptides can improve these symptoms, though the timeline is slow and they’re not a replacement for thyroid hormone optimization [6].
Can You Stack CJC-1295 and Ipamorelin?
Not only can you stack them - this is the most common way they’re prescribed. The two peptides are synergistic by design. CJC-1295 amplifies GH production at the GHRH receptor while ipamorelin triggers release at the ghrelin receptor. Hit both pathways simultaneously and total GH output exceeds what either peptide achieves alone [3].
Standard Stacking Protocol
The most widely prescribed approach: inject both peptides subcutaneously, on an empty stomach (no food for at least 90 minutes before or 30 minutes after), once or twice daily. Common timing splits include:
- Before bed only: Both peptides together, 100-300 mcg each, to amplify the natural nighttime GH surge
- Morning and evening split: Ipamorelin in the morning (fasted), CJC-1295 in the evening before bed [5]
- Twice daily, both compounds: 100 mcg of each, morning and evening, for more aggressive protocols
Cycling is standard practice. A three-month-on, two-week-off protocol prevents receptor desensitization and maintains the pituitary’s responsiveness to the peptides [1]. Some clinicians run longer cycles at lower doses, but the three-on/two-off framework is the most established.
What to Expect from the Stack
The first week typically brings deeper sleep and more vivid dreams [4]. Weeks two through four, recovery between training sessions improves noticeably. By month two, body composition shifts start becoming visible - subtle at first, then more obvious. The full effect of the stack on fat loss and lean mass usually peaks around the three-month mark [3].
One practical note: the combination compresses appetite windows for some users, making intermittent fasting easier to sustain [4]. This isn’t a direct appetite-suppression effect - it’s likely a downstream consequence of improved sleep and more stable GH/cortisol rhythms.
Alternative Stacks
Ipamorelin also pairs well with tesamorelin, a different GHRH analog that’s FDA-approved for HIV-associated lipodystrophy. The ipamorelin-tesamorelin stack is gaining traction as an alternative to the CJC combo, with early anecdotal reports suggesting superior fat-loss outcomes compared to traditional GH protocols [2]. If visceral fat reduction is the primary objective, the tesamorelin swap may be worth discussing with your prescriber.
Read the Full Guide(s)
References
- High Intensity Health - Peptides 101: CJC-1295 + Ipamorelin for GH & Body Composition (https://www.youtube.com/watch?v=pz5x5DpVbQk)
- MPMD - Ipamorelin + Tessamorelin Peptide Stack for Fat Loss (https://www.youtube.com/watch?v=riDoapSVb3g)
- Dr. Gabrielle Lyon - CJC-1295/Ipamorelin for Growth Hormone (https://www.youtube.com/watch?v=073WMTTRzO8)
- High Intensity Health - Personal CJC + Ipamorelin Sleep Outcome (https://www.youtube.com/watch?v=SsFndSNVXIk)
- Ben Greenfield - Ipamorelin/CJC-1295 Stack Benefits (https://www.youtube.com/watch?v=j9oZL05aoo0)
- Ben Greenfield - CJC-1295 and Ipamorelin for Thyroid-Related Symptoms (https://www.youtube.com/watch?v=wdQqmTkn6xg)